(Q51079335)

28 March 2018

title

Naltrexone alteration of acute smoking response in nicotine-dependent subjects. (English)

1 reference

28 March 2018

0 references

King AC

1

1 reference

28 March 2018

Meyer PJ

series ordinal

2

1 reference

28 March 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

28 March 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

28 March 2018

volume

66

1 reference

28 March 2018

issue

3

1 reference

28 March 2018

page(s)

563-572

1 reference

28 March 2018

Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naltrexone blockade of nicotine effects in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Opiate antagonists reduce cocaine but not nicotine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naltrexone effects on short-term and long-term smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effect of naloxone on cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Signs and symptoms of tobacco withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naloxone reduces cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

An inventory for the measurement of self-reported stress and arousal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naloxone precipitates nicotine abstinence syndrome in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effects of naltrexone on mood and neuroendocrine function in normal adult males

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Alcohol increases cigarette smoking: a laboratory demonstration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naloxone does not affect cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effects of single doses of alcohol and caffeine on cigarette smoke puffing behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Stress and arousal in sedative and stimulant cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Volitional oral intake of nicotine in tupaias: drug-induced alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Individual differences in stress and arousal during cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Chronic and acute tolerance to subjective effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Endogenous opioids and smoking: a review of progress and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Neuroregulatory effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Effects of alcohol cues on smoking urges and topography among alcoholic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

A self-administered Short Michigan Alcoholism Screening Test (SMAST)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naltrexone, smoking behaviour and cigarette withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

The development and initial validation of a questionnaire on smoking urges

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900258-6

7 January 2021

10.1016/S0091-3057(00)00258-6

Identifiers

DOI

1 reference

28 March 2018

PubMed ID

10899371

1 reference

28 March 2018